{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:14:15Z","timestamp":1791980055943,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019125","name":"Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020699","name":"Institut de Cardiom\u00e9tabolisme et Nutrition","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jacl.2018.07.009","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:25:16Z","timestamp":1532478316000},"page":"1420-1435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue"],"prefix":"10.1016","volume":"12","author":[{"given":"Emilie","family":"Capel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Vatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Disse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-S\u00e9gol\u00e8ne","family":"Cottereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Verpont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e9na","family":"Mosbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gourdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Barraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Z\u00fcchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Bonnefond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Froguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Christin-Maitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Delemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"F\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Laville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tenenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lascols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"J\u00e9ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2018.07.009_bib1","series-title":"Lectures illustrative of various subjects in pathology and surgery","first-page":"275","author":"Brodie","year":"1846"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.009_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ijo.0801867","article-title":"Multiple symmetric lipomatosis: clinical aspects and outcome in a long-term longitudinal study","volume":"26","author":"Enzi","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.009_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00005792-198401000-00004","article-title":"Multiple symmetric lipomatosis: an updated clinical report","volume":"63","author":"Enzi","year":"1984","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.009_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00131402-200309000-00001","article-title":"Multiple symmetric lipomatosis (Madelung's Disease) caused by the MERRF (A8344G) mutation: a report of two cases and review of the literature","volume":"5","author":"Chong","year":"2003","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.jacl.2018.07.009_bib5","doi-asserted-by":"crossref","first-page":"e23813","DOI":"10.7554\/eLife.23813","article-title":"Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression","volume":"6","author":"Rocha","year":"2017","journal-title":"Elife"},{"issue":"18","key":"10.1016\/j.jacl.2018.07.009_bib6","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/hmg\/ddv229","article-title":"Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy","volume":"24","author":"Sawyer","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"40","key":"10.1016\/j.jacl.2018.07.009_bib7","doi-asserted-by":"crossref","first-page":"11249","DOI":"10.1073\/pnas.1606786113","article-title":"Critical reappraisal confirms that Mitofusin 2 is an endoplasmic reticulum-mitochondria tether","volume":"113","author":"Naon","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 5","key":"10.1016\/j.jacl.2018.07.009_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1242\/jcs.114.5.867","article-title":"Control of mitochondrial morphology by a human mitofusin","volume":"114","author":"Santel","year":"2001","journal-title":"J Cell Sci"},{"issue":"11","key":"10.1016\/j.jacl.2018.07.009_bib9","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.15252\/embj.201694914","article-title":"Mfn2 is critical for brown adipose tissue thermogenic function","volume":"36","author":"Boutant","year":"2017","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.jacl.2018.07.009_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/ars.2007.1934","article-title":"Mitofusin 2: a mitochondria-shaping protein with signaling roles beyond fusion","volume":"10","author":"de Brito","year":"2008","journal-title":"Antioxid Redox Signal"},{"issue":"14","key":"10.1016\/j.jacl.2018.07.009_bib11","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1073\/pnas.1108220109","article-title":"Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis","volume":"109","author":"Sebastian","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.009_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yexcr.2017.08.006","article-title":"Disruption of the mitochondria-associated ER membrane (MAM) plays a central role in palmitic acid-induced insulin resistance","volume":"359","author":"Shinjo","year":"2017","journal-title":"Exp Cell Res"},{"issue":"12","key":"10.1016\/j.jacl.2018.07.009_bib13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1089\/ars.2014.6208","article-title":"Mitofusin 2 as a driver that controls energy metabolism and insulin signaling","volume":"22","author":"Zorzano","year":"2015","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"10.1016\/j.jacl.2018.07.009_bib14","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamaneurol.2014.629","article-title":"Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features","volume":"71","author":"Bombelli","year":"2014","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.jacl.2018.07.009_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ng1341","article-title":"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A","volume":"36","author":"Zuchner","year":"2004","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.jacl.2018.07.009_bib16","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archneurol.2009.284","article-title":"Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations","volume":"66","author":"Calvo","year":"2009","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.009_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jns.12117","article-title":"MFN2 deletion of exons 7 and 8: founder mutation in the UK population","volume":"20","author":"Carr","year":"2015","journal-title":"J Peripher Nerv Syst"},{"issue":"19","key":"10.1016\/j.jacl.2018.07.009_bib18","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1212\/01.wnl.0000311275.89032.22","article-title":"Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations","volume":"70","author":"Nicholson","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jacl.2018.07.009_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jns.12145","article-title":"Mutational mechanisms in MFN2-related neuropathy: compound heterozygosity for recessive and semidominant mutations","volume":"20","author":"Piscosquito","year":"2015","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.009_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1212\/WNL.0b013e3182242d4d","article-title":"Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations","volume":"77","author":"Polke","year":"2011","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jacl.2018.07.009_bib21","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/NEN.0b013e31818b6cbc","article-title":"Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations","volume":"67","author":"Vallat","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.009_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrendo.2014.185","article-title":"Biology of upper-body and lower-body adipose tissue--link to whole-body phenotypes","volume":"11","author":"Karpe","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.jacl.2018.07.009_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cmet.2013.03.008","article-title":"Mechanisms and metabolic implications of regional differences among fat depots","volume":"17","author":"Tchkonia","year":"2013","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.jacl.2018.07.009_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.numecd.2015.01.010","article-title":"Multiple symmetric lipomatosis: a rare disease and its possible links to brown adipose tissue","volume":"25","author":"Enzi","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.009_bib25","first-page":"253","article-title":"Multiple symmetric lipomatosis. Ultrastructural investigation of the tissue and preadipocytes in primary culture","volume":"63","author":"Zancanaro","year":"1990","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.009_bib26","doi-asserted-by":"crossref","first-page":"E444","DOI":"10.1152\/ajpendo.00691.2006","article-title":"Unexpected evidence for active brown adipose tissue in adult humans","volume":"293","author":"Nedergaard","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.009_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","article-title":"FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0","volume":"37","author":"Boellaard","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.jacl.2018.07.009_bib28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2265.2011.04208.x","article-title":"Histological and molecular features of lipomatous and nonlipomatous adipose tissue in familial partial lipodystrophy caused by LMNA mutations","volume":"76","author":"Ara\u00fajo-Vilar","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5685","key":"10.1016\/j.jacl.2018.07.009_bib29","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1099793","article-title":"Structural basis of mitochondrial tethering by mitofusin complexes","volume":"305","author":"Koshiba","year":"2004","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jacl.2018.07.009_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/dom.12606","article-title":"One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes","volume":"18","author":"Vatier","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10.1016\/j.jacl.2018.07.009_bib31","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00256-016-2457-9","article-title":"Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases","volume":"45","author":"Teboul-Core","year":"2016","journal-title":"Skeletal Radiol"},{"issue":"42","key":"10.1016\/j.jacl.2018.07.009_bib32","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1093\/eurheartj\/ehv307","article-title":"Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases","volume":"36","author":"Wahbi","year":"2015","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jacl.2018.07.009_bib33","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy","volume":"364","author":"Gandotra","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.07.009_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cyto.2016.04.015","article-title":"Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy","volume":"83","author":"Miehle","year":"2016","journal-title":"Cytokine"},{"issue":"15","key":"10.1016\/j.jacl.2018.07.009_bib35","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.009_bib36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11307-008-0177-9","article-title":"Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h","volume":"11","author":"Chin","year":"2009","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"10.1016\/j.jacl.2018.07.009_bib37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ejrad.2013.01.008","article-title":"Standardized uptake values for [18F] FDG in normal organ tissues: comparison of whole-body PET\/CT and PET\/MRI","volume":"82","author":"Heusch","year":"2013","journal-title":"Eur J Radiol"},{"issue":"8","key":"10.1016\/j.jacl.2018.07.009_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jcmg.2010.06.004","article-title":"Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging","volume":"3","author":"Christen","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.009_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/oby.20957","article-title":"Visceral and subcutaneous adipose tissue FDG uptake by PET\/CT in metabolically healthy obese subjects","volume":"23","author":"Oliveira","year":"2015","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"10.1016\/j.jacl.2018.07.009_bib40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.20344\/amp.8712","article-title":"Metabolic activity in the visceral and subcutaneous adipose tissues by FDG-PET\/CT in obese patients","volume":"30","author":"Monteiro","year":"2017","journal-title":"Acta Med Port"},{"issue":"5","key":"10.1016\/j.jacl.2018.07.009_bib41","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jacl.2018.07.009_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00241817","article-title":"The skeleton in congenital, generalized lipodystrophy: evaluation using whole-body radiographic surveys, magnetic resonance imaging and technetium-99m bone scintigraphy","volume":"21","author":"Fleckenstein","year":"1992","journal-title":"Skeletal Radiol"},{"issue":"22","key":"10.1016\/j.jacl.2018.07.009_bib43","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1212\/WNL.0b013e318294b44c","article-title":"Phenotypic heterogeneity of the 8344A>G mtDNA \u201cMERRF\u201d mutation","volume":"80","author":"Mancuso","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jacl.2018.07.009_bib44","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/ene.12954","article-title":"Peripheral neuropathy is a common manifestation of mitochondrial diseases: a single-centre experience","volume":"23","author":"Luigetti","year":"2016","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.009_bib45","doi-asserted-by":"crossref","first-page":"a001156","DOI":"10.1101\/mcs.a001156","article-title":"Optic atrophy, cataracts, lipodystrophy\/lipoatrophy, and peripheral neuropathy caused by a de novo OPA3 mutation","volume":"3","author":"Bourne","year":"2017","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.009_bib46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1172\/JCI88883","article-title":"The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis","volume":"127","author":"Crewe","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jacl.2018.07.009_bib47","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cmet.2014.07.025","article-title":"Brown fat in humans: consensus points and experimental guidelines","volume":"20","author":"Cypess","year":"2014","journal-title":"Cell Metab"},{"issue":"15","key":"10.1016\/j.jacl.2018.07.009_bib48","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jacl.2018.07.009_bib49","first-page":"CS117","article-title":"Clinical findings of hibernoma of the buttock and thigh: rare involvements and extremely high uptake of FDG-PET","volume":"15","author":"Nishida","year":"2009","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.jacl.2018.07.009_bib50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/cen.12095","article-title":"Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives","volume":"78","author":"Woo","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7642","key":"10.1016\/j.jacl.2018.07.009_bib51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature21365","article-title":"Adipose-derived circulating mRNAs regulate gene expression in other tissues","volume":"542","author":"Thomou","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2018.07.009_bib52","doi-asserted-by":"crossref","first-page":"10275","DOI":"10.1038\/srep10275","article-title":"Serum FGF21 levels are associated with brown adipose tissue activity in humans","volume":"5","author":"Hanssen","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.009_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrendo.2016.136","article-title":"Brown adipose tissue as a secretory organ","volume":"13","author":"Villarroya","year":"2017","journal-title":"Nat Rev Endocrinol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418303106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418303106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:33:51Z","timestamp":1761831231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418303106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1933287418303106"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.07.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}